Overview

Update
Total Equity Funding
$84.4M in 6 Rounds from 5 Investors
Most Recent Funding
$25.49M Series E on November 1, 2013
Headquarters:
Martillac
Description:
Implanet is a biotechnology company that provides implants for healthcare professionals treating orthopaedic patients.
Founders:
Categories:
Medical Device, Health Care, Biotechnology
Website:
http://www.implanet.com

Company Details

Update
Founded:
2007
Contact:
33 5 57 99 55 55
Employees:
11 - 50 | 3 in Crunchbase

IMPLANET’s mission is to provide Gold Standard implants of uncompromising and indisputable quality to the various surgical markets. It is destined to healthcare professionals treating orthopaedic patients.

Implanet is the first and only company that provides modern solutions (services, along with Gold Standard products) that allow healthcare professionals to improve their productivity while contributing to society’s urgent need to reduce healthcare costs. They believe that today, companies can evolve in the context of globalization while being socially and economically responsible.

This organisation and business model provide an unprecedented level of security and information to the healthcare community.

Funding Rounds (6) - $84.4M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2013€18.7M / Series E1
Sep, 2011€5.32M / Series D1
Jul, 2010$10.1M / Series D3
Apr, 2010€8M / Series C5
Jun, 2009€9M / Series B4
May, 2007€13M / Series A3

Current Team (3)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    Technopole Bordeaux Montesquieu

    Allée François Magendie

    Martillac, 33650

    FRA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos